Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 822 entries
Sorted by: Best Match Show Resources per page
“Shift-and-persist” strategies: Why low socioeconomic status isn't always bad for health

socioeconomic status & related terms (e.g., low income)

Chen E, Miller GE.
GSID: mzLvXnmddIgJ
E Chen, GE Miller - Perspectives on psychological science, 2012 - journals.sagepub.com

… term, low SES is a risk factor for many chronic diseases of aging by describing the family and neighborhood environments associated with low … (eg, decreasing income inequality), low-…

Cite
Chen, E., & Miller, G. E. (2012). “Shift-and-persist” strategies: Why low socioeconomic status isn’t always bad for health. Perspectives on psychological science, 7(2), 135-158.
Chen, Edith, and Gregory E. Miller. "“Shift-and-persist” strategies: Why low socioeconomic status isn’t always bad for health." Perspectives on psychological science 7.2 (2012): 135-158.
Copy Download .nbib Format: MLA
[Objectivation and prediction of clinical groups by statistical manipulation of experimental psychological dates].

Zeitschrift fur Psychologie mit Zeitschrift fur angewandte Psychologie

Berner C, Berner P, Gabriel E, Gloning K, Küfferle B, Müller E, Trappl R.
PMID: 4403166
Z Psychol Z Angew Psychol. 1971;179(3):368-80.

No abstract available.

Cite
Berner C, Berner P, Gabriel E, et al. Objektivierung und Voraussage klinischer Gruppierungen durch statistiche Verarbeitung experimentalpsychologischer Daten. [Objectivation and prediction of clinical groups by statistical manipulation of experimental psychological dates]. Z Psychol Z Angew Psychol. 1971;179(3):368-80
Berner, C., Berner, P., Gabriel, E., Gloning, K., Küfferle, B., Müller, E., & Trappl, R. (1971). Objektivierung und Voraussage klinischer Gruppierungen durch statistiche Verarbeitung experimentalpsychologischer Daten. [Objectivation and prediction of clinical groups by statistical manipulation of experimental psychological dates]. Zeitschrift fur Psychologie mit Zeitschrift fur angewandte Psychologie, 179(3), 368-80.
Berner, C, et al. "Objektivierung und Voraussage klinischer Gruppierungen durch statistiche Verarbeitung experimentalpsychologischer Daten." [Objectivation and prediction of clinical groups by statistical manipulation of experimental psychological dates]. Zeitschrift fur Psychologie mit Zeitschrift fur angewandte Psychologie vol. 179,3 (1971): 368-80.
Berner C, Berner P, Gabriel E, Gloning K, Küfferle B, Müller E, Trappl R. Objektivierung und Voraussage klinischer Gruppierungen durch statistiche Verarbeitung experimentalpsychologischer Daten. [Objectivation and prediction of clinical groups by statistical manipulation of experimental psychological dates]. Z Psychol Z Angew Psychol. 1971;179(3):368-80. German. PMID: 4403166.
Copy Download .nbib Format: NLM
Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan.

Archives of virology

Wen L, Nakayama M, Yamanishi Y, Nishio O, Fang Z-, Nakagomi O, Araki K, Nishimura S, Hasegawa A, Müller WEG, Ushijima H.
PMID: 28879402
Arch Virol. 1997 Jul;142(7):1481-1489. doi: 10.1007/s007050050174.

Sequence analysis of the VP7 gene was performed on twenty-one human isolates of serotype 3 related-rotavirus in China and Japan. The five Chinese isolates were found to be not similar to the 16 Japanese isolates and to SAff11 (simian...

Cite
Wen L, Nakayama M, Yamanishi Y, et al. Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan. Arch Virol. 1997;142(7):1481-1489doi: 10.1007/s007050050174.
Wen, L., Nakayama, M., Yamanishi, Y., Nishio, O., Fang, Z. -., Nakagomi, O., Araki, K., Nishimura, S., Hasegawa, A., Müller, W. E. G., & Ushijima, H. (1997). Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan. Archives of virology, 142(7), 1481-1489. https://doi.org/10.1007/s007050050174
Wen, L, et al. "Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan." Archives of virology vol. 142,7 (1997): 1481-1489. doi: https://doi.org/10.1007/s007050050174
Wen L, Nakayama M, Yamanishi Y, Nishio O, Fang Z-, Nakagomi O, Araki K, Nishimura S, Hasegawa A, Müller WEG, Ushijima H. Genetic Variation in the VP7 Gene of Human Rotavirus Serotype 3 (G3 Type) Isolated in China and Japan. Arch Virol. 1997 Jul;142(7):1481-1489. doi: 10.1007/s007050050174. PMID: 28879402.
Copy Download .nbib Format: NLM
Course Setting as a Prevention Measure for Overuse Injuries of the Back in Alpine Ski Racing: A Kinematic and Kinetic Study of Giant Slalom and Slalom.

Orthopaedic journal of sports medicine

Spörri J, Kröll J, Fasel B, Aminian K, Müller E.
PMID: 26977419
Orthop J Sports Med. 2016 Feb 25;4(2):2325967116630719. doi: 10.1177/2325967116630719. eCollection 2016 Feb.

BACKGROUND: A combination of frontal bending, lateral bending, and torsion in the loaded trunk has been suggested to be a mechanism leading to overuse injuries of the back in Alpine ski racing. However, there is limited knowledge about the...

Cite
Spörri J, Kröll J, Fasel B, et al. Course Setting as a Prevention Measure for Overuse Injuries of the Back in Alpine Ski Racing: A Kinematic and Kinetic Study of Giant Slalom and Slalom. Orthop J Sports Med. 2016;4(2):2325967116630719doi: 10.1177/2325967116630719.
Spörri, J., Kröll, J., Fasel, B., Aminian, K., & Müller, E. (2016). Course Setting as a Prevention Measure for Overuse Injuries of the Back in Alpine Ski Racing: A Kinematic and Kinetic Study of Giant Slalom and Slalom. Orthopaedic journal of sports medicine, 4(2), 2325967116630719. https://doi.org/10.1177/2325967116630719
Spörri, Jörg, et al. "Course Setting as a Prevention Measure for Overuse Injuries of the Back in Alpine Ski Racing: A Kinematic and Kinetic Study of Giant Slalom and Slalom." Orthopaedic journal of sports medicine vol. 4,2 (2016): 2325967116630719. doi: https://doi.org/10.1177/2325967116630719
Spörri J, Kröll J, Fasel B, Aminian K, Müller E. Course Setting as a Prevention Measure for Overuse Injuries of the Back in Alpine Ski Racing: A Kinematic and Kinetic Study of Giant Slalom and Slalom. Orthop J Sports Med. 2016 Feb 25;4(2):2325967116630719. doi: 10.1177/2325967116630719. eCollection 2016 Feb. PMID: 26977419; PMCID: PMC4772347.
Copy Download .nbib Format: NLM
The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable.

Interface focus

Nickerson D, Atalag K, de Bono B, Geiger J, Goble C, Hollmann S, Lonien J, Müller W, Regierer B, Stanford NJ, Golebiewski M, Hunter P.
PMID: 27051515
Interface Focus. 2016 Apr 06;6(2):20150103. doi: 10.1098/rsfs.2015.0103.

Reconstructing and understanding the Human Physiome virtually is a complex mathematical problem, and a highly demanding computational challenge. Mathematical models spanning from the molecular level through to whole populations of individuals must be integrated, then personalized. This requires interoperability...

Cite
Nickerson D, Atalag K, de Bono B, et al. The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable. Interface Focus. 2016;6(2):20150103doi: 10.1098/rsfs.2015.0103.
Nickerson, D., Atalag, K., de Bono, B., Geiger, J., Goble, C., Hollmann, S., Lonien, J., Müller, W., Regierer, B., Stanford, N. J., Golebiewski, M., & Hunter, P. (2016). The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable. Interface focus, 6(2), 20150103. https://doi.org/10.1098/rsfs.2015.0103
Nickerson, David, et al. "The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable." Interface focus vol. 6,2 (2016): 20150103. doi: https://doi.org/10.1098/rsfs.2015.0103
Nickerson D, Atalag K, de Bono B, Geiger J, Goble C, Hollmann S, Lonien J, Müller W, Regierer B, Stanford NJ, Golebiewski M, Hunter P. The Human Physiome: how standards, software and innovative service infrastructures are providing the building blocks to make it achievable. Interface Focus. 2016 Apr 06;6(2):20150103. doi: 10.1098/rsfs.2015.0103. PMID: 27051515; PMCID: PMC4759754.
Copy Download .nbib Format: NLM
Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing.

Biochemistry and biophysics reports

Müller WEG, Tolba E, Dorweiler B, Schröder HC, Diehl-Seifert B, Wang X.
PMID: 29124179
Biochem Biophys Rep. 2015 Aug 10;3:150-160. doi: 10.1016/j.bbrep.2015.08.007. eCollection 2015 Sep.

BACKGROUND: While electrospun materials have been frequently used in tissue engineering no wound dressings exist that significantly improved wound healing effectively.METHODS: We succeeded to fabricate three-dimensional (3D) electrospun poly(D,l-lactide) (PLA) fiber mats into which nanospheres, formed from amorphous calcium...

Cite
Müller WEG, Tolba E, Dorweiler B, et al. Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing. Biochem Biophys Rep. 2015;3:150-160doi: 10.1016/j.bbrep.2015.08.007.
Müller, W. E. G., Tolba, E., Dorweiler, B., Schröder, H. C., Diehl-Seifert, B., & Wang, X. (2015). Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing. Biochemistry and biophysics reports, 3150-160. https://doi.org/10.1016/j.bbrep.2015.08.007
Müller, Werner E G, et al. "Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing." Biochemistry and biophysics reports vol. 3 (2015): 150-160. doi: https://doi.org/10.1016/j.bbrep.2015.08.007
Müller WEG, Tolba E, Dorweiler B, Schröder HC, Diehl-Seifert B, Wang X. Electrospun bioactive mats enriched with Ca-polyphosphate/retinol nanospheres as potential wound dressing. Biochem Biophys Rep. 2015 Aug 10;3:150-160. doi: 10.1016/j.bbrep.2015.08.007. eCollection 2015 Sep. PMID: 29124179; PMCID: PMC5668879.
Copy Download .nbib Format: NLM
Very high productivity of the C.

Oecologia

Morison JIL, Piedade MTF, Müller E, Long SP, Junk WJ, Jones MB.
PMID: 28547335
Oecologia. 2000 Nov;125(3):400-411. doi: 10.1007/s004420000464. Epub 2000 Nov 01.

Fluxes of CO

Cite
Morison JIL, Piedade MTF, Müller E, et al. Very high productivity of the C. Oecologia. 2000;125(3):400-411doi: 10.1007/s004420000464.
Morison, J. I. L., Piedade, M. T. F., Müller, E., Long, S. P., Junk, W. J., & Jones, M. B. (2000). Very high productivity of the C. Oecologia, 125(3), 400-411. https://doi.org/10.1007/s004420000464
Morison, J I L, et al. "Very high productivity of the C." Oecologia vol. 125,3 (2000): 400-411. doi: https://doi.org/10.1007/s004420000464
Morison JIL, Piedade MTF, Müller E, Long SP, Junk WJ, Jones MB. Very high productivity of the C. Oecologia. 2000 Nov;125(3):400-411. doi: 10.1007/s004420000464. Epub 2000 Nov 01. PMID: 28547335.
Copy Download .nbib Format: NLM
Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages.

Frontiers in immunology

Müller E, Christopoulos PF, Halder S, Lunde A, Beraki K, Speth M, Øynebråten I, Corthay A.
PMID: 29123526
Front Immunol. 2017 Oct 26;8:1383. doi: 10.3389/fimmu.2017.01383. eCollection 2017.

Tumor-associated macrophages may either promote or suppress tumor growth depending on their activation status. Interferon-γ (IFN-γ) has been identified as a key factor for inducing tumoricidal M1 phenotype in macrophages. However, it remains unclear whether IFN-γ is sufficient or...

Cite
Müller E, Christopoulos PF, Halder S, et al. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages. Front Immunol. 2017;8:1383doi: 10.3389/fimmu.2017.01383.
Müller, E., Christopoulos, P. F., Halder, S., Lunde, A., Beraki, K., Speth, M., Øynebråten, I., & Corthay, A. (2017). Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages. Frontiers in immunology, 81383. https://doi.org/10.3389/fimmu.2017.01383
Müller, Elisabeth, et al. "Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages." Frontiers in immunology vol. 8 (2017): 1383. doi: https://doi.org/10.3389/fimmu.2017.01383
Müller E, Christopoulos PF, Halder S, Lunde A, Beraki K, Speth M, Øynebråten I, Corthay A. Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages. Front Immunol. 2017 Oct 26;8:1383. doi: 10.3389/fimmu.2017.01383. eCollection 2017. PMID: 29123526; PMCID: PMC5662546.
Copy Download .nbib Format: NLM
A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical

Freedman MS, Wolinsky JS, Truffinet P, Comi G, Kappos L, Miller AE, Olsson TP, Benamor M, Chambers S, O'Connor PW.
PMID: 28607708
Mult Scler J Exp Transl Clin. 2015 Dec 07;1:2055217315618687. doi: 10.1177/2055217315618687. eCollection 2015.

BACKGROUND: Teriflunomide is a once-daily oral immunomodulator for the treatment of relapsing-remitting MS.OBJECTIVE: To evaluate the safety and tolerability of teriflunomide as add-on therapy to a stable dose of glatiramer acetate (GA) in patients with relapsing forms of MS...

Cite
Freedman MS, Wolinsky JS, Truffinet P, et al. A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis. Mult Scler J Exp Transl Clin. 2015;1:2055217315618687doi: 10.1177/2055217315618687.
Freedman, M. S., Wolinsky, J. S., Truffinet, P., Comi, G., Kappos, L., Miller, A. E., Olsson, T. P., Benamor, M., Chambers, S., & O'Connor, P. W. (2015). A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis. Multiple sclerosis journal - experimental, translational and clinical, 12055217315618687. https://doi.org/10.1177/2055217315618687
Freedman, M S, et al. "A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis." Multiple sclerosis journal - experimental, translational and clinical vol. 1 (2015): 2055217315618687. doi: https://doi.org/10.1177/2055217315618687
Freedman MS, Wolinsky JS, Truffinet P, Comi G, Kappos L, Miller AE, Olsson TP, Benamor M, Chambers S, O'Connor PW. A randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis. Mult Scler J Exp Transl Clin. 2015 Dec 07;1:2055217315618687. doi: 10.1177/2055217315618687. eCollection 2015. PMID: 28607708; PMCID: PMC5433345.
Copy Download .nbib Format: NLM
Bulk heterojunction nanomorphology of fluorenyl hexa-peri-hexabenzocoronene-fullerene blend films.

ACS applied materials & interfaces

Pfaff M, Müller P, Bockstaller P, Müller E, Subbiah J, Wong WW, Klein MF, Kiersnowski A, Puniredd SR, Pisula W, Colsmann A, Gerthsen D, Jones DJ.
PMID: 24143919
ACS Appl Mater Interfaces. 2013 Nov 27;5(22):11554-62. doi: 10.1021/am4044085. Epub 2013 Nov 05.

In this study, the nanomorphology of fluorenyl hexa-peri-hexabenzocoronene:[6,6]-phenyl C61-butyric acid methyl ester (FHBC:PC61BM) absorber layers of organic solar cells was investigated. Different electron microscopical techniques, atomic force microscopy, and grazing incidence wide-angle X-ray scattering were applied for a comprehensive...

Cite
Pfaff M, Müller P, Bockstaller P, et al. Bulk heterojunction nanomorphology of fluorenyl hexa-peri-hexabenzocoronene-fullerene blend films. ACS Appl Mater Interfaces. 2013;5(22):11554-62doi: 10.1021/am4044085.
Pfaff, M., Müller, P., Bockstaller, P., Müller, E., Subbiah, J., Wong, W. W., Klein, M. F., Kiersnowski, A., Puniredd, S. R., Pisula, W., Colsmann, A., Gerthsen, D., & Jones, D. J. (2013). Bulk heterojunction nanomorphology of fluorenyl hexa-peri-hexabenzocoronene-fullerene blend films. ACS applied materials & interfaces, 5(22), 11554-62. https://doi.org/10.1021/am4044085
Pfaff, Marina, et al. "Bulk heterojunction nanomorphology of fluorenyl hexa-peri-hexabenzocoronene-fullerene blend films." ACS applied materials & interfaces vol. 5,22 (2013): 11554-62. doi: https://doi.org/10.1021/am4044085
Pfaff M, Müller P, Bockstaller P, Müller E, Subbiah J, Wong WW, Klein MF, Kiersnowski A, Puniredd SR, Pisula W, Colsmann A, Gerthsen D, Jones DJ. Bulk heterojunction nanomorphology of fluorenyl hexa-peri-hexabenzocoronene-fullerene blend films. ACS Appl Mater Interfaces. 2013 Nov 27;5(22):11554-62. doi: 10.1021/am4044085. Epub 2013 Nov 05. PMID: 24143919.
Copy Download .nbib Format: NLM
Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone.

Beilstein journal of nanotechnology

Wang X, Schröder HC, Müller WE.
PMID: 24991497
Beilstein J Nanotechnol. 2014 May 12;5:610-21. doi: 10.3762/bjnano.5.72. eCollection 2014.

Calcium carbonate is the material that builds up the spicules of the calcareous sponges. Recent results revealed that the calcium carbonate/biocalcite-based spicular skeleton of these animals is formed through an enzymatic mechanism, such as the skeleton of the siliceous...

Cite
Wang X, Schröder HC, Müller WE. Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone. Beilstein J Nanotechnol. 2014;5:610-21doi: 10.3762/bjnano.5.72.
Wang, X., Schröder, H. C., & Müller, W. E. (2014). Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone. Beilstein journal of nanotechnology, 5610-21. https://doi.org/10.3762/bjnano.5.72
Wang, Xiaohong, et al. "Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone." Beilstein journal of nanotechnology vol. 5 (2014): 610-21. doi: https://doi.org/10.3762/bjnano.5.72
Wang X, Schröder HC, Müller WE. Biocalcite, a multifunctional inorganic polymer: Building block for calcareous sponge spicules and bioseed for the synthesis of calcium phosphate-based bone. Beilstein J Nanotechnol. 2014 May 12;5:610-21. doi: 10.3762/bjnano.5.72. eCollection 2014. PMID: 24991497; PMCID: PMC4077312.
Copy Download .nbib Format: NLM
Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Freedman MS, Montalban X, Miller AE, Dive-Pouletty C, Leist TP.
PMID: 27200909
Value Health. 2014 Nov;17(7):A392. doi: 10.1016/j.jval.2014.08.864. Epub 2014 Oct 26.

No abstract available.

Cite
Freedman MS, Montalban X, Miller AE, et al. Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis. Value Health. 2014;17(7):A392doi: 10.1016/j.jval.2014.08.864.
Freedman, M. S., Montalban, X., Miller, A. E., Dive-Pouletty, C., & Leist, T. P. (2014). Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A392. https://doi.org/10.1016/j.jval.2014.08.864
Freedman, M S, et al. "Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A392. doi: https://doi.org/10.1016/j.jval.2014.08.864
Freedman MS, Montalban X, Miller AE, Dive-Pouletty C, Leist TP. Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of "Number Needed to Treat" Analysis. Value Health. 2014 Nov;17(7):A392. doi: 10.1016/j.jval.2014.08.864. Epub 2014 Oct 26. PMID: 27200909.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 822 entries